Genentech, Inc.
Time frame: 1 February 2023 - 31 January 2024Article ‘Count’ and ‘Share’ for Genentech, Inc. based on listed parameters only.
The articles listed below published by authors from Genentech, Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
American Journal of Human Genetics |
1 | 0.05 |
Cancer Cell |
1 | 0.04 |
Cancer Research |
1 | 0.02 |
Cell |
2 | 0.71 |
Cell Stem Cell |
1 | 1.00 |
Journal of Biological Chemistry |
1 | 1.00 |
Journal of Clinical Investigation |
1 | 0.04 |
Nature |
7 | 1.83 |
Nature Biotechnology |
3 | 1.19 |
Nature Cell Biology |
1 | 0.06 |
Nature Communications |
18 | 6.96 |
Nature Genetics |
2 | 0.01 |
Nature Immunology |
1 | 0.05 |
Nature Neuroscience |
2 | 0.21 |
Neuron |
1 | 0.81 |
PLOS Genetics |
1 | 0.76 |
Proceedings of the National Academy of Sciences of the United States of America |
1 | 0.25 |
Science |
1 | 0.12 |
Science Advances |
3 | 1.11 |
Science Translational Medicine |
3 | 0.63 |
The EMBO Journal |
1 | 0.07 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.